Up to 6-year performance and clinical outcomes of balloon expandable transcatheter aortic valve according to the implantation strategy: insight from the DIRECTAVI trial

Back

ESC Professional Premium Access

Up to 6-year performance and clinical outcomes of balloon expandable transcatheter aortic valve according to the implantation strategy: insight from the DIRECTAVI trial

Session: Advances and remaining challenges in percutaneous valve intervention

Topic: Intervention

Speaker: Professor F. Leclercq (Montpellier, FR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Professor Florence Leclercq

University Hospital Arnaud de Villeneuve, Montpellier (France)

0 follower

7 more presentations in this session

Early outcomes of the PASCAL P10 and the MitraClip XT transcatheter mitral leaflet approximation devices - A propensity score matched multicentre comparison

Speaker: Doctor P. von Stein (Cologne, DE)

Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation - Results from the SOLVE-TAVI trial

Speaker: Doctor H. Feistritzer (Leipzig, DE)

Clinical and neurocognitive outcomes in patients with supra-arch vascular disease following transcatheter aortic valve replacement

Speaker: Doctor T. Ko (Taipei, TW)

Influence of device generations on alternations of mitral annulus after transcatheter edge-to-edge repair: a real-time three-dimensional transesophageal echocardiography study

Speaker: Ms M. Ohmori (Tokyo, JP)

Prevalence and predictors of pacemaker implantation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: TAVI-NOR study

Speaker: Mr D. Wasim (Bergen, NO)

Access the full session

Advances and remaining challenges in percutaneous valve intervention

Speakers: Professor F. Leclercq, Doctor P. von Stein, Doctor H. Feistritzer, Doctor T. Ko, Ms M. Ohmori...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Up to 6-year performance and clinical outcomes of balloon expandable transcatheter aortic valve according to the implantation strategy: insight from the DIRECTAVI trial

About the speaker

Professor Florence Leclercq

7 more presentations in this session

Early outcomes of the PASCAL P10 and the MitraClip XT transcatheter mitral leaflet approximation devices - A propensity score matched multicentre comparison

Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation - Results from the SOLVE-TAVI trial

Clinical and neurocognitive outcomes in patients with supra-arch vascular disease following transcatheter aortic valve replacement

Influence of device generations on alternations of mitral annulus after transcatheter edge-to-edge repair: a real-time three-dimensional transesophageal echocardiography study

Prevalence and predictors of pacemaker implantation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: TAVI-NOR study

Access the full session

Advances and remaining challenges in percutaneous valve intervention

About the event

ESC Congress 2023

ESC 365 is supported by